Phibro Animal Health | PAHC - 债务

金融业

USD

USD 1.5B

现金及等价物

USD 61.42M

USD 240.42M

USD 935.51M

USD 316.47M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 385.48M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.5B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 534.88M

贸易债权人

USD 127.31M

应收帐款人

USD 215.87M

	债务	更改		日
Align Technology	USD 116.04M		1.6M	2026-03
ANI Pharmaceuticals	USD 613.76M		3.28M	2026-03
Aurora Cannabis	CAD 23.86M		76.48M	2026-03
Bristol-Myers Squibb	USD 46.43B		711M	2026-03
Canopy Growth	CAD 278.71M		19.38M	2026-03
Corcept Therapeutics	USD 9.64M		3.53M	2026-03
Eli Lilly	USD 43.37B		867M	2026-03
Henry Schein	USD 3.81B		64M	2026-06
Idexx Laboratories	USD 1.1B		9.37M	2026-06
Knight Therapeutics	CAD 77.91M		28.33M	2025-12
Merck	USD 49.12B		222M	2026-03
Nektar Therapeutics	USD 0		0	2022-06
Pacira	USD 363.12M		4.53M	2026-06
Phibro Animal Health	USD 474.17M		730K	2024-09
Prestige Brands	USD 1.05B		33.86M	2026-03
Supernus Pharmaceuticals	USD 40.17M		733K	2026-06
Zoetis	USD 9.24B		0	2026-03